Navigation Links
Bone Biologics Announces a Major US Patent Issuance For Its Recombinant Protein Process For the Formation of Cartilage
Date:3/11/2010

Bruce A. Hazuka, President and CEO of Bone Biologics, Inc. credited the company's partner, the Musculoskeletal Transplant Foundation (MTF) for its ongoing financial and strategic support. "MTF is essential to our progress toward realizing the full potential of the UCB-1 protein as a platform technology."

"We are pleased to continue our partnership with Bone Biologics," noted Bruce Stroever, CEO of MTF. "This latest patent issuance is a clear sign that the company is continuing to make very good progress toward FDA approval and commercialization of an important product."

Musculoskeletal Transplant Foundation

MTF is a non-profit service organization dedicated to providing quality tissue through a commitment to excellence in education, research, recovery and care for recipients, donors and their families. In 2009, MTF distributed over 415,000 tissue grafts.

Bone Biologics, Inc.


'/>"/>
SOURCE Bone Biologics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Specialists Are Turning to Biologics Earlier in the Treatment of Psoriasis and Psoriatic Arthritis
2. Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG
3. AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune
4. Biotest Pharmaceuticals Corporation Completes Acquisition of Nabi Biologics Business Unit
5. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
6. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
7. MedImmune Submits Biologics License Application to FDA for Motavizumab
8. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
9. Study by Leading Economist Identifies Potential for $378 Billion of Savings From Follow On Biologics
10. Biologics, Derma Fillers are Key to Dermatological Drug Market Growth
11. Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... --  Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ) ... 35 th Annual Health Care Conference on Tuesday, March ... .  Lexicon management will provide an overview of Lexicon,s ... the presentation will be available through Lexicon,s website at ... available at www.lexpharma.com until April 3, 2015. ...
(Date:2/26/2015)... Calif. , Feb. 26, 2015 CytomX, ... of cancer, today announced that Sean McCarthy , ... overview at the upcoming Cowen and Company 35 th ... . Dr. McCarthy,s presentation will take place at ... About CytomX Therapeutics CytomX Therapeutics develops Probody™ therapeutics ...
(Date:2/26/2015)... 2015 Caris Life Sciences® today announced ... Genitourinary Cancers Symposium in Orlando, Fla. ... tumor profiling. Both studies utilized Caris Molecular Intelligence™, ... identify biomarkers that shed light on potential treatment ... bladder cancer (SCBC). In one ...
(Date:2/25/2015)... Technologies Inc. (TSX-V: RTI) (the "Corporation") announced today that ... quarter of its fiscal year ended March 31, 2015. ... the CEO & CFO certifications for the three and ... on www.SEDAR.com . CFO ... pleased to announce the appointment of Prakash Hariharhan as ...
Breaking Biology Technology:Lexicon To Present At The Cowen 35th Annual Health Care Conference 2Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 2Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 3Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 4Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 5Radient Technologies Inc. Releases Third Quarter Results and Appoints New Interim CFO 2
... CRY ), a,biomaterials, medical device and tissue processing company, ... Annual Piper Jaffray Health,Care Conference at The New York Palace ... Anderson, president and chief executive officer of CryoLife,Inc., will provide ... 2:30 p.m. Eastern Time. , ...
... The Global Probiotics Council,(GPC), a committee formed ... the availability of two grants for the second ... Each Young,Investigator Grant will provide $50,000 over one ... role of probiotics and gastrointestinal microbiota in health,and ...
... Queen,s University Belfast is to become the United Kingdom,s ... ,cyber-attacks, after a funding boost from the Engineering and ... the EPSRC will help fund a new Innovation and ... (CSIT) - which will be based at Queen,s Institute ...
Cached Biology Technology:CryoLife to Present at 20th Annual Piper Jaffray Health Care Conference 2New Young Investigator Grants for Probiotics Research Announced 2New Young Investigator Grants for Probiotics Research Announced 3New Young Investigator Grants for Probiotics Research Announced 4Queen's secures £25M for UK's cyber safety 2
(Date:2/24/2015)... 24, 2015 Research and Markets ... the "Global 2D Gesture Recognition Market 2015-2019" ... The analysts forecast the Global 2D Gesture Recognition ... over the period 2014-2019 The increased ... is one of the major trends in the ...
(Date:2/12/2015)... , Feb. 12, 2015   MedNet Solutions ... in clinical study management systems, has recently bolstered ... further distinguishing iMedNet as ... Organizations (CROs) and healthcare consultants.  Building on the ... customer referrals and numerous co-marketing opportunities), MedNet,s new ...
(Date:2/5/2015)... PARK, North Carolina , 5. Februar ... 35. Jahr als spezialisiertes Logistikunternehmen und hat ... als einzige klinische Logistikfirma (Clinical Logistics Organization ... Kernbotschaft der neuen Kampagne lautet First ... Lieferungen. Foto: http://photos.prnewswire.com/prnh/20150205/173753 ...
Breaking Biology News(10 mins):Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3
... first time, scientists have shown that amniotic fluid (the ... new source of stem cells for therapeutic applications. The ... Blood , the official journal of the American ... other scientists, our research team wondered whether stem cells ...
... that its latest journal, Disease Models & Mechanisms ... MEDLINE. MEDLINE (http://www.pubmed.gov) is the premier bibliographic database of ... National Institutes of Health (NIH), MEDLINE contains over 16 million ... DMM has been recommended for inclusion by ...
... Md. (Mar. 31, 2009) Octogenarian women were unable to ... targeted at strengthening the thigh muscle, according to a ... . The results are surprising because previous studies have ... for people who are into their 70s. An increase ...
Cached Biology News:Amniotic fluid may provide new source of stem cells for future therapies 2Amniotic fluid may provide new source of stem cells for future therapies 3Disease Models & Mechanisms -- selected for indexing in Medline 2As good as it gets: Octogenarian muscles don't get stronger with exercise 2As good as it gets: Octogenarian muscles don't get stronger with exercise 3
Homo sapiens olfactomedin 1, transcript variant 3...
... agarose-digesting enzyme isolated from Pseudomonas atlantica. ... in agarose producing carbohydrate molecules that ... carbohydrate molecules will not interfere with ... Gelzyme enzyme can be used for ...
... the cellular components necessary for protein synthesis ... termination factors) but has not been treated ... primarily for the isolation of these components ... globin mRNA. Untreated Lysate is prepared from ...
...
Biology Products: